Optimal treatment for the secondary prevention of stroke in hypertensive patients

• Conditions: Patients with arterial hypertension and a previous stroke or transient ischaemic attack; Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]

• Registration Number: EUCTR2012-001757-21-ES
• Lead Sponsor: Istituto Auxologico Italiano

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-09-16
• Last Update Posted: 27 January 2014

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 7500

Inclusion Criteria

Stroke or transient ischaemic attack during 1 to 6 month preceding randomization; age: 65 years or older; Only hypertensive patients; Patients untreated with statin with LDL-cholesterol > 2.8 mmol/L; Patients treated with statins with any LDL-cholestrol value.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 7500

Exclusion Criteria

Patients in unstable clinical conditions; Patients with haemodynamically significant carotid stenosis or requiring carotid revascularization.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified